Pages that link to "Q34360151"
Jump to navigation
Jump to search
The following pages link to Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice (Q34360151):
Displaying 43 items.
- Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy (Q27301945) (← links)
- Membrane damage-induced vesicle-vesicle fusion of dysferlin-containing vesicles in muscle cells requires microtubules and kinesin. (Q28301480) (← links)
- Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ mice (Q30503686) (← links)
- Bone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement. (Q30552419) (← links)
- Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). (Q33608787) (← links)
- Influence of immune responses in gene/stem cell therapies for muscular dystrophies (Q33736192) (← links)
- The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands. (Q33808490) (← links)
- Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice (Q33878140) (← links)
- Bcl-2 inhibits the innate immune response during early pathogenesis of murine congenital muscular dystrophy (Q33995531) (← links)
- Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure. (Q34028416) (← links)
- Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response (Q34103354) (← links)
- Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophy (Q34149744) (← links)
- A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy (Q35100498) (← links)
- CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy (Q35632288) (← links)
- Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle (Q35669024) (← links)
- Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice (Q35779807) (← links)
- Heterogeneous characteristics of Korean patients with dysferlinopathy (Q35859252) (← links)
- Meeting Report: New Directions in the Biology and Disease of Skeletal Muscle 2014 (Q35869849) (← links)
- Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages (Q35923265) (← links)
- Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice (Q35984257) (← links)
- Dysferlin and animal models for dysferlinopathy (Q36085192) (← links)
- Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf (tm1Kcam) (Q36155837) (← links)
- Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis (Q36240722) (← links)
- Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy. (Q36388825) (← links)
- Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle (Q37234561) (← links)
- Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane (Q37409431) (← links)
- Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration (Q38008341) (← links)
- Dysferlin-deficient muscular dystrophy and innate immune activation. (Q38092854) (← links)
- Skeletal muscle heat shock protein 70: diverse functions and therapeutic potential for wasting disorders (Q38165929) (← links)
- Immune-mediated pathology in Duchenne muscular dystrophy (Q38561435) (← links)
- Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites (Q39015003) (← links)
- Muscle membrane repair and inflammatory attack in dysferlinopathy. (Q42209023) (← links)
- Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. (Q48020261) (← links)
- Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle (Q51089580) (← links)
- Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. (Q54520022) (← links)
- Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice (Q64061047) (← links)
- Muscle, myeloid cells, and complement: a complex interaction (Q89001606) (← links)
- Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin (Q90029822) (← links)
- Mouse models for muscular dystrophies: an overview (Q90733720) (← links)
- Immunobiology of Inherited Muscular Dystrophies (Q91446266) (← links)
- DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts (Q92386005) (← links)
- SIRT1 deficiency interferes with membrane resealing after cell membrane injury (Q93046172) (← links)
- Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates (Q93340309) (← links)